化疗药物型栓塞剂介入治疗宫颈癌的临床探讨.docVIP

化疗药物型栓塞剂介入治疗宫颈癌的临床探讨.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
化疗药物型栓塞剂介入治疗宫颈癌的临床探讨.doc

化疗药物型栓塞剂介入治疗宫颈癌的临床探讨   [摘要] 目的 探讨使用化疗药物型栓塞剂介入栓塞治疗宫颈癌的疗效及不良反应。方法 对该院于2010年1月―2013年12月收治的150例宫颈癌患者进行子宫动脉介入栓塞化疗,随机分为治疗组和对照组,治疗组采用化疗药物型栓塞剂栓塞;对照组采用化疗药物动脉灌注后再行碘油乳剂栓塞,其后均用大颗粒明胶海绵栓塞。总结分析近期疗效、骨髓抑制反应及主要胃肠道反应。结果 治疗组有效率为82.50%,对照组有效率为84.29%,差异无统计学意义(P0.05)。但对照治疗后骨髓抑制反应及主要胃肠道反应两组差异明显。结论 使用化疗药物型栓塞剂的患者治疗后不良反应明显小于对照组,患者易于接受,而疗效与对照组无明显差别。   [关键词] 宫颈癌;化疗药物型栓塞剂;介入治疗   [中图分类号] R737.33 [文献标识码] A [文章编号] 1674-0742(2015)06(a)-0105-03   Clinical Observation of Interventional Treatment with Chemotherapy Embolization Agent for Cervical Cancer   LI Ling-ling, LIU Wei, YUE Qing-fen   Department of Gynecology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan Province, 471009 China   [Abstract] Objective To observe the efficacy and adverse reactions of interventional treatment with chemotherapy embolization agent for cervical cancer. Methods The 150 cases of cervical cancer patients with uterine artery embolization chemotherapy were randomly divided into treatment group and control group, the treatment group received chemotherapy embolization agent; the control group arterial infusion chemotherapy after the line lipiodol emulsion embolization are subsequently gelfoam embolization with large particles. Summary analysis of short-term effect, bone marrow suppression response and major gastrointestinal reactions. Results Efficiency of the control group, 82.50%, had no statistically significant difference with that, 84.29%, of the treatment group(P?0.05), but the bone marrow suppression and major gastrointestinal effects of the the two groups were significant differences. Conclusion Adverse reactions in patients after treatment of chemotherapy embolization agent is significantly less than that in the patients of the control group, so this method is easily accepted for patients, but there was no significant difference in the efficacy of the two groups.   [Key words] Cervical cancer; Type of embolic agent chemotherapy; Interventional chemotherapy   宫颈癌发病率居于妇科恶性肿瘤首

文档评论(0)

lnainai_sj + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档